forked from zotero/translators
-
Notifications
You must be signed in to change notification settings - Fork 0
/
Copy pathJBJS Am.js
201 lines (184 loc) · 10.1 KB
/
JBJS Am.js
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
{
"translatorID": "8a325571-c2a8-417a-8a25-b1dca65154c3",
"label": "JBJS Am",
"creator": "Max Gordon and Avram Lyon",
"target": "^https?://(?:www\\.)?jbjs.org[^\\/]*/(?:searchresults|issue|article)\\.aspx",
"minVersion": "1.0",
"maxVersion": "",
"priority": 100,
"inRepository": true,
"translatorType": 4,
"browserSupport": "gcsib",
"lastUpdated": "2011-09-05 06:38:30"
}
/*
JBJS Translator
Copyright (C) 2011 Max Gordon and Avram Lyon
This program is free software: you can redistribute it and/or modify
it under the terms of the GNU Affero General Public License as published by
the Free Software Foundation, either version 3 of the License, or
(at your option) any later version.
This program is distributed in the hope that it will be useful,
but WITHOUT ANY WARRANTY; without even the implied warranty of
MERCHANTABILITY or FITNESS FOR A PARTICULAR PURPOSE. See the
GNU Affero General Public License for more details.
You should have received a copy of the GNU Affero General Public License
along with this program. If not, see <http://www.gnu.org/licenses/>.
*/
/*
This translator is derived from the Wiley Online Library translator, which
was first written by Sean Takats and Michael Berkowitz.
*/
function detectWeb(doc, url){
var namespace = doc.documentElement.namespaceURI;
var nsResolver = namespace ? function(prefix) {
if (prefix == 'x') return namespace; else return null;
} : null;
if (url.match(/\/issue|\/searchresults/)) {
return "multiple";
} else return "journalArticle";
}
function doWeb(doc, url){
var namespace = doc.documentElement.namespaceURI;
var nsResolver = namespace ? function(prefix) {
if (prefix == 'x') return namespace; else return null;
} : null;
var host = 'http://' + doc.location.host + "/";
var urls = new Array();
if(detectWeb(doc, url) == "multiple") { //search
var title;
var availableItems = new Array();
var articles = doc.evaluate('//div[@class="articleContent"]//a[@class="relatedArticle"]', doc, nsResolver, XPathResult.ANY_TYPE, null);
//Zotero.debug(articles);
var article = false;
while (article = articles.iterateNext()) {
availableItems[article.href] = article.textContent;
}
Zotero.selectItems(availableItems, function (items) {
if(!items) {
return true;
}
for (var i in items) {
urls.push(i);
}
Zotero.Utilities.processDocuments(urls, scrape, function () { Zotero.done(); });
});
} else { //single article
scrape(doc, url);
}
Zotero.wait();
}
function scrape(doc,url)
{
var namespace = doc.documentElement.namespaceURI;
var nsResolver = namespace ? function(prefix) {
if (prefix == 'x') return namespace; else return null;
} : null;
var newItem=new Zotero.Item("journalArticle");
var temp;
var xpath;
var row;
var rows;
newItem.url = doc.location.href;
var metaTags = doc.getElementsByTagName("meta");
var pages = [false, false];
var doi = false;
var pdf = false;
var html = false;
for (var i = 0; i< metaTags.length; i++) {
var tag = metaTags[i].getAttribute("name");
var value = metaTags[i].getAttribute("content");
//Zotero.debug(pages + pdf + html);
//Zotero.debug("Have meta tag: " + tag + " => " + value);
switch (tag) {
// Google.
case "citation_journal_title": if (!newItem.publicationTitle) newItem.publicationTitle = value; break;
case "citation_journal_abbrev": if (!newItem.journalAbbreviation) newItem.journalAbbreviation = value; break;
case "citation_author":
newItem.creators.push(Zotero.Utilities.cleanAuthor(value, "author", true));
case "citation_title": if (!newItem.title) newItem.title = value; break;
case "citation_publisher": if (!newItem.publisher) newItem.publisher = value; break;
case "citation_date": if (!newItem.date && value != "NaN" && value != "") newItem.date = value; break;
case "citation_year": if (!newItem.date && value != "NaN" && value != "") newItem.date = value; break;
case "citation_volume": if (!newItem.volume && value != "NaN" && value != "") newItem.volume = value; break;
case "citation_issue": if (!newItem.issue && value != "NaN" && value != "") newItem.issue = value; break;
case "citation_firstpage": if (!pages[0] && value != "NaN" && value != "") pages[0] = value; break;
case "citation_lastpage": if (!pages[1] && value != "NaN" && value != "") pages[1] = value; break;
case "citation_issn": if (!newItem.ISSN && value != "NaN" && value != "") newItem.ISSN = value; break;
case "citation_isbn": if (!newItem.ISBN && value != "NaN" && value != "") newItem.ISBN = value; break;
case "citation_doi": if (!newItem.DOI) newItem.DOI = value; break;
case "citation_reference": break; // These are citations in the paper-- Z doesn't use them
default:
Zotero.debug("Ignoring meta tag: " + tag + " => " + value);
}
}
if (pages[0] && pages[1]) newItem.pages = pages.join('-')
else newItem.pages = pages[0] ? pages[1] : (pages[1] ? pages[1] : "");
// Get the abstract
var abstractNode = doc.evaluate('//div[h2/text()="Abstract"]/following-sibling::div[1]', doc, nsResolver, XPathResult.ANY_TYPE, null).iterateNext();
if (abstractNode) newItem.abstractNote = abstractNode.textContent;
newItem.complete();
}
/** BEGIN TEST CASES **/
var testCases = [
{
"type": "web",
"url": "http://www.jbjs.org/article.aspx?articleid=35426",
"items": [
{
"itemType": "journalArticle",
"creators": [
{
"firstName": "Delamarter",
"lastName": "Rick",
"creatorType": "author"
},
{
"firstName": "Zigler",
"lastName": "Jack E. ",
"creatorType": "author"
},
{
"firstName": "Balderston",
"lastName": "Richard A. ",
"creatorType": "author"
},
{
"firstName": "Cammisa",
"lastName": "Frank P. ",
"creatorType": "author"
},
{
"firstName": "Goldstein",
"lastName": "Jeffrey A. ",
"creatorType": "author"
},
{
"firstName": "Spivak",
"lastName": "Jeffrey M. ",
"creatorType": "author"
}
],
"notes": [],
"tags": [],
"seeAlso": [],
"attachments": [],
"url": "http://www.jbjs.org/article.aspx?articleid=35426",
"publicationTitle": "The Journal of Bone and Joint Surgery (American)",
"journalAbbreviation": "JBJS",
"title": "Prospective, Randomized, Multicenter Food and Drug Administration Investigational Device Exemption Study of the ProDisc-L Total Disc Replacement Compared with Circumferential Arthrodesis for the Treatment of Two-Level Lumbar Degenerative Disc Disease: Results at Twenty-four Months",
"volume": "93",
"issue": "8",
"date": "4/20/2011 12:00:00 AM",
"ISSN": "0021-9355",
"DOI": "10.2106/JBJS.I.00680",
"publisher": "The Journal of Bone and Joint Surgery",
"pages": "705-715",
"abstractNote": "Background: \n Disc replacement arthroplasty previously has been shown to be an effective alternative to spine fusion for the treatment of single-level lumbar degenerative disc disease. The purpose of the present study was to determine the twenty-four-month results of a clinical trial of the ProDisc-L total disc replacement as compared with spinal fusion for the treatment of degenerative disc disease at two contiguous vertebral levels from L3 to S1.Methods: \n A total of 237 patients were treated in a randomized controlled trial designed as a non-inferiority study for regulatory application purposes. Blocked randomization was performed with use of a 2:1 ratio of total disc arthroplasty to circumferential arthrodesis. Evaluations, including patient self-assessments, physical and neurological examinations, and radiographic examinations, were performed preoperatively, six weeks postoperatively, and three, six, twelve, eighteen, and twenty-four months postoperatively.Results: \n At twenty-four months, 58.8% (eighty-seven) of 148 patients in the total disc replacement group were classified as a statistical success, compared with 47.8% (thirty-two) of sixty-seven patients in the arthrodesis group; non-inferiority was demonstrated. The mean Oswestry Disability Index in both groups significantly improved from baseline (p < 0.0001); the mean percentage improvement for the total disc replacement group was significantly better than that for the arthrodesis group (p = 0.0282). An established clinical criterion for success, a =15-point improvement in the Oswestry Disability Index from baseline, occurred in 73.2% (109) of 149 patients in the total disc replacement group and 59.7% (thirty-seven) of sixty-two patients in the arthrodesis group. The Short Form-36 physical component scores were significantly better for the total disc replacement group as compared with the arthrodesis group (p = 0.0141 at twenty-four months). Visual analog scale scores for satisfaction significantly favored total disc replacement from three to twenty-four months. At twenty-four months, 78.2% (111) of 142 patients in the total disc replacement group and 62.1% (thirty-six) of fifty-eight patients in the arthrodesis group responded “yes” when asked if they would have the same surgery again. Lumbar spine range of motion on radiographs averaged 7.8° at the superior disc and 6.2° at the inferior disc in patients with total disc replacement. Reduction in narcotics usage significantly favored the total disc replacement group at twenty-four months after surgery (p = 0.0020).Conclusions: \n Despite the relatively short duration of follow-up and design limitations, the present study suggests that two-level lumbar disc arthroplasty is an alternative to and offers clinical advantages in terms of pain relief and functional recovery in comparison with arthrodesis. Longer-term follow-up is needed to determine the risks for implant wear and/or degenerative segment changes.Level of Evidence: \n Therapeutic Level I. See Instructions to Authors for a complete description of levels of evidence.",
"libraryCatalog": "JBJS Am",
"shortTitle": "Prospective, Randomized, Multicenter Food and Drug Administration Investigational Device Exemption Study of the ProDisc-L Total Disc Replacement Compared with Circumferential Arthrodesis for the Treatment of Two-Level Lumbar Degenerative Disc Disease"
}
]
}
]
/** END TEST CASES **/